Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans. (Q46413810)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 September 2012

Language	Label	Description	Also known as
English	Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.	scientific article published on 19 September 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

enzyme replacement therapy

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

6

object named as

Lodewijk Ijlst

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Frits A Wijburg

13

object named as

Frits A Wijburg

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Carla E M Hollak

5

object named as

Carla E M Hollak

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Minke H de Ru

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Linda van der Tol

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Naomi van Vlies

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Wim Kulik

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Henk van Lenthe

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Muhammad A Saif

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Tom Wagemans

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Willem M van der Wal

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Ronald J Wanders

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

publication date

19 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Journal of Inherited Metabolic Disease

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

247-255

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22991166 AND SRC:MED&resulttype=core&format=json

13 February 2020

Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder.

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Enzyme-replacement therapy in mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Mucopolysaccharidosis I: management and treatment guidelines

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Recombinant expression, purification, and kinetic characterization of chondroitinase AC and chondroitinase B from Flavobacterium heparinum

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapy.

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Heparin cofactor II–thrombin complex: A biomarker of MPS disease

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Heparin cofactor II–thrombin complex in MPS I: A biomarker of MPS disease

1 reference

https://api.crossref.org/works/10.1007/S10545-012-9538-2

21 January 2018

Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22991166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal observations of serum heparin cofactor II-thrombin complex in treated Mucopolysaccharidosis I and II patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22991166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22991166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/22991166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22991166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I

1 reference

https://pubmed.ncbi.nlm.nih.gov/22991166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I

1 reference

https://pubmed.ncbi.nlm.nih.gov/22991166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I

1 reference

https://pubmed.ncbi.nlm.nih.gov/22991166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/22991166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46413810&oldid=2246172120"